FORT LAUDERDALE, Fla., Sept. 18, 2017 -- Patriot National, Inc. (NYSE:PN) (the “Company”) announced today that its Board of Directors has set Friday, December 15, 2017 as the date of the Company’s 2017 Annual Meeting of Stockholders for the purpose of electing Class II directors.
About Patriot National
Patriot National, Inc. is a national provider of comprehensive technology and outsourcing solutions that help insurance companies and employers mitigate risk, comply with complex regulations and save time and money. Patriot National provides general agency services, technology outsourcing, software solutions, specialty underwriting and policyholder services, claims administration services, and self-funded health plans to its insurance carrier clients, employers and other clients. Patriot National is headquartered in Fort Lauderdale, Florida. For more information about Patriot National, please visit www.patnat.com.
Media and Investor Contact:
Cindy Campbell
Director of Investor Relations
Patriot National, Inc.
(954) 670-2907
[email protected]


GLP-1 Weight Loss Pills Set to Reshape Food and Fast-Food Industry in 2025
South Korean Court Clears Korea Zinc’s $7.4 Billion U.S. Smelter Project, Shares Surge
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies
ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants
BP Nears $10 Billion Castrol Stake Sale to Stonepeak
Waymo Plans Safety and Emergency Response Upgrades After San Francisco Robotaxi Disruptions
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector
Moore Threads Unveils New GPUs, Fuels Optimism Around China’s AI Chip Ambitions
DOJ Reaches Settlement With Blackstone’s LivCor Over Alleged Rent Price-Fixing
Nike Stock Jumps After Apple CEO Tim Cook Buys $2.9M Worth of Shares
Texas App Store Age Verification Law Blocked by Federal Judge in First Amendment Ruling
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Boeing Wins $2.04B U.S. Air Force Contract for B-52 Engine Replacement Program
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio 



